MedPage Today (1/23, Frieden) reported the American Psychiatric Association is suing New York-based health plan EmblemHealth “over its alleged use of ‘ghost networks’ that list mental health [professionals] that are not in their network or aren’t taking new patients.” The class action lawsuit, filed Dec. 30 in federal court, “alleges that the ghost network directory ‘constitutes unlawful deceptive acts and practices, false advertising, and violations of statutory and regulatory requirements,’” according to an APA press release. The networks “[harm] clinicians’ reputations by listing them in provider directories when they do not accept the plan’s insurance or do not practice at the locations where they are listed,” the release noted. The APA “seeks punitive damages and a jury trial.”

Related Links:

— MedPage Today (requires login and subscription)

Psychiatric News (1/22) reports a study found that “just one-quarter of intensive eating disorder treatment facilities – such as inpatient hospitals or residential programs – accept Medicaid,” while “more than 90% of these facilities accept private insurance.” For the study, “384 eating disorder centers offering intensive outpatient care, partial or full hospitalization, and/or residential treatment care were identified across 45 states and the District of Columbia. Of these, 101 (26.3%) located across 35 states accepted Medicaid. In contrast, 94% of eating disorder centers accepted private insurance, while 6% accepted no insurance. Medicaid acceptance was highest (64%) at treatment centers that offered inpatient care.” Notably, among treatment centers operated by one of six large chains, “just 13% accepted Medicaid.” The study was published in Psychiatric Services.

Related Links:

— “Intensive Eating Disorder Treatment Out-of-Reach for Many Medicaid Beneficiaries , Psychiatric News , January 22, 2026

The Washington Post (1/22, Johnson) reports, “Obesity in midlife may cause vascular dementia later in life by raising blood pressure over decades and quietly damaging brain vessels, according to new research released Thursday.” The study, published in the Journal of Clinical Endocrinology & Metabolism, found that “having a higher body mass index increases the risk of vascular dementia by roughly 50 to 60 percent.” An association between dementia and obesity “has long been the subject of study, and the new research strongly indicates there is indeed a link.”
        
ABC News (1/22, Cobern, Charles) reports the study provides “the strongest evidence to date showing a direct relationship between BMI and the increased risk of developing vascular dementia, a risk heavily influenced by elevated blood pressure.” Investigators “say these findings highlight how important reducing these risk factors are to help prevent this form of dementia and protect brain health.”

Related Links:

— “The Washington Post (requires login and subscription)

HealthDay (1/21, Thompson) reports a study found that lesbian or bisexual women “had a 38% higher likelihood of alcohol being involved in their death by suicide compared to heterosexual women,” and were “more likely to be intoxicated at the time of their death.” The researchers “analyzed data collected by the federal National Violent Death Reporting System between 2013 and 2021. The data involved nearly 219,000 people who died by suicide, including 3,425 LGB people.” The results indicated “that LGB women had a 15% higher likelihood of detectable blood alcohol content following their death by suicide. They also were 17% more likely to be intoxicated when they” died by “suicide, researchers found.” Researchers noted they “found no similar association among gay or bisexual men when it comes to alcohol and suicide.” The study was discussed in a JAMA Network Open research letter.

Related Links:

— “Alcohol Tied To Suicide Risk Among Lesbian, Bisexual Women,”Dennis Thompson, HealthDay, January 21, 2026

MedPage Today (1/21, Jeffrey) reports a survey study found that “regular use of generative artificial intelligence (AI) was associated with greater levels of depressive symptoms.” Researchers observed that “in sociodemographic-adjusted regression models, daily use of AI was associated with greater levels of depressive symptoms as measured by the 9-item Patient Health Questionnaire, as was use multiple times per day, compared with no use.” They also found that greater AI use was “associated with a higher likelihood of reporting at least moderate depressive symptoms, that clinicians would typically refer for evaluation and treatment.” The study was published in JAMA Network Open.

Related Links:

— MedPage Today (requires login and subscription)